Peripheral benzodiazepine receptors and mitochondrial function

• Published in: Neurochemistry international Vol. 40; no. 6; pp. 475 - 486
• Main Authors: Casellas, Pierre, Galiegue, Sylvaine, Basile, Anthony S
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2002
• Subjects: Animals; Humans; Mitochondria; Mitochondria - drug effects; Mitochondria - ultrastructure; Mitochondrial permeability transition; Neurosteroids; Peripheral benzodiazepine receptors; Peripheral Nerves - drug effects; PK11195; Receptors, GABA-A - drug effects; Ro5-4864; Ro5-4864; Mitochondrial permeability transition; Neurosteroids; PK11195; AIF, apoptosis inducing factor; GABA, γ-aminobutyric acid; ANC, adenine nucleotide carrier; DBI, diazepam binding inhibitor; CNS, central nervous system; Mitochondria; MPTP, mitochondrial permeability transition pore; VDAC, voltage-dependent anion channel; Peripheral benzodiazepine receptors; Apaf-1, apoptosis activating factor 1; ROS, reactive oxygen species; PBR, peripheral benzodiazepine receptor; CBR, central benzodiazepine receptor
• ISSN: 0197-0186; 1872-9754
• DOI: 10.1016/S0197-0186(01)00118-8

For over 20 years, numerous investigations have focused on elucidating the function of the peripheral benzodiazepine receptor (PBR). This relatively small protein (18 kDa) arouses great interest because of its association with numerous biological functions, including the regulation of cellular proliferation, immunomodulation, porphyrin transport and heme biosynthesis, anion transport, regulation of steroidogenesis and apoptosis. Although the receptor was first identified as a binding site for the benzodiazepine, diazepam, in peripheral organ systems, the PBR was subsequently found to be distinct from the central benzodiazepine receptor (CBR) in terms of its pharmacological profile, structure, subcellular localization, tissue distribution and physiological functions. The PBR is widely expressed throughout the body, with high densities found in steroid-producing tissues. In contrast, its expression in the CNS is restricted to ependymal cells and glia. The benzodiazepine Ro5-4864 and the isoquinoline carboxamide PK11195 exhibit nanomolar affinity for the PBR, and are the archtypic pharmacological tools for characterizing the receptor and its function. Primary among these functions are its regulation of steroidogenesis and apoptosis, which reflect its mitochondrial localization and involvement in oxidative processes. This review will evaluate the basic pharmacology and molecular biology of the PBR, and highlight its role in regulating mitochondrial function, the mitochondrial transmembrane potential and its sensitivity to reactive oxygen species (ROS), and neurosteroid synthesis, processes relevant to the pathogenesis of a number of neurological and neuropsychiatric disorders.